Samyang Genex opens new cGMP plant for injectables

Published: 2007-10-26 06:57:00

Updated: 2007-10-26 06:57:00

Samyang Genex starts the operation of its newly established cGMP plant in Daejeon for production of injectables, such as Genexol injection, said a company spokesman on October 23.

The injectable plant, which acquired the nation's KGMP certification in December of 2005, will manufacture two typ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK